GGrantIndex
← Search

LAMIVUDINE IN PTS W/ CHRONIC HEPATITIS B--TREATMENT NAIVE

$0M01FY2000RRNIH

University Of Washington, Seattle WA

Investigators

Linked publications & trials

Abstract

-To compare the efficacy of lamivudine versus placebo in patients with chronic hepatitis B infection who are treatment naive with regard to improvements in liver histology and HBeAG seroconversion rates. -To evaluate the safety of the two treatment regimens. -To assess population based pharmacokinetics in this patient population. -To explore the impacts of the two treatment on occupational productivity.

View original record on NIH RePORTER →